Dr. Robertson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13330 Usf Laurel Dr
Tampa, FL 33612Phone+1 813-974-3541Fax+1 813-974-9145
Education & Training
University of South Florida MorsaniResidency, Neurology, 2008 - 2012- University of South Florida College of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2012 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients Start of enrollment: 2014 Mar 01
- A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) Start of enrollment: 2019 Jul 22
Roles: Principal Investigator
Publications & Presentations
PubMed
- Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.Yang Mao-Draayer, Amit Bar-Or, Konstantin Balashov, John Foley, Kyle Smoot
Advances in Therapy. 2025-01-01 - Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.Scott D Newsome, Lawrence Goldstick, Derrick S Robertson, James D Bowen, Robert T Naismith
Annals of Clinical and Translational Neurology. 2024-12-01 - 1 citationsTime-Dependent Deep Learning Prediction of Multiple Sclerosis Disability.John D Mayfield, Ryan Murtagh, John Ciotti, Derrick Robertson, Issam El Naqa
Journal of Imaging Informatics in Medicine. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
